Immunological veterinary medicinal products, including vaccines, are authorised for horses.
Search results 26 to 32 from a total of 32
| Name | Description | Marketing Authorisation Holder | License Number | License Date | Animal | Further Information |
|---|---|---|---|---|---|---|
|
Arti-Cell Forte |
Allogene periphere mesenchymale Stammzellen aus dem Blut vom Pferd, chondrogeninduziert |
Global Stem cell Technology (G.S.T.) NV, Belgien |
EU/2/18/228 | 29.03.2019 | Pferd | |
|
Tetanus-Serum WdT |
Serum gegen Tetanus |
Wirtschaftsgenossenschaft deutscher Tierärzte e.G. |
A258/79 | 27.12.2005 | Pferd, Hund, Schaf | |
|
Equilis- Tetanus- Serum |
Serum gegen Tetanus |
Intervet Deutschland GmbH |
A164/79d | 23.12.2005 | Pferd, Hund, Schaf | |
|
Equip Artervac |
Equine Arteritis |
Zoetis Deutschland GmbH |
PEI.V.01240.01.1 | 23.05.2002 | Pferd, Pony | |
|
Equip F |
Pferdeinfluenza |
Zoetis Deutschland GmbH |
PEI.V.02824.01.1 | 21.10.2003 | Pferd, Pony | |
|
Equip FT |
Pferdeinfluenza, Tetanus |
Zoetis Deutschland GmbH |
PEI.V.02825.01.1 | 21.10.2003 | Pferd, Pony | |
|
Prevaccinol |
Rhinopneumonitis |
Intervet Deutschland GmbH |
A196/79 | 22.03.2004 | Pferd, Pony |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 25.04.2025
